Weaver C. Barksdale & Associates, Inc. Pfizer Inc Transaction History
Weaver C. Barksdale & Associates, Inc.
- $109 Million
- Q1 2024
A detailed history of Weaver C. Barksdale & Associates, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Weaver C. Barksdale & Associates, Inc. holds 34,454 shares of PFE stock, worth $958,854. This represents 0.88% of its overall portfolio holdings.
Number of Shares
34,454
Previous 34,858
1.16%
Holding current value
$958,854
Previous $1 Million
4.69%
% of portfolio
0.88%
Previous 0.98%
Shares
12 transactions
Others Institutions Holding PFE
# of Institutions
3,158Shares Held
3.68BCall Options Held
67.4MPut Options Held
113M-
Vanguard Group Inc Valley Forge, PA507MShares$14.1 Billion0.28% of portfolio
-
Black Rock Inc. New York, NY431MShares$12 Billion0.28% of portfolio
-
State Street Corp Boston, MA291MShares$8.09 Billion0.37% of portfolio
-
Wellington Management Group LLP Boston, MA178MShares$4.95 Billion0.89% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA122MShares$3.4 Billion0.79% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $156B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...